"
Team:KIT-Kyoto/Notebook/Meeting/March
From 2011.igem.org
(Difference between revisions)
| Line 7: | Line 7: | ||
!align="left"|[[Team:KIT-Kyoto|Home]] > [[Team:KIT-Kyoto/Notebook|Note book]] > [[Team:KIT-Kyoto/Notebook/Meeting|Meeting]] | !align="left"|[[Team:KIT-Kyoto|Home]] > [[Team:KIT-Kyoto/Notebook|Note book]] > [[Team:KIT-Kyoto/Notebook/Meeting|Meeting]] | ||
| - | !align="right"|Language：[[Team:KIT-Kyoto/Notebook/Meeting/March|English]]/[[Team:KIT-Kyoto/ | + | !align="right"|Language：[[Team:KIT-Kyoto/Notebook/Meeting/March|English]]/[[Team:KIT-Kyoto/MeetingJ3|Japanese]] |
|} | |} | ||
<div id=NAKAMI> | <div id=NAKAMI> | ||
Revision as of 10:10, 9 September 2011
 |
|
| Home | Team | Project | Parts | Notebook | Safety | Human Practice | Attributions |
|---|
| Home > Note book > Meeting | Language：English/Japanese |
|---|
2nd March
- at laboratory on 3rd floor
- <Participants>
- Yoshimura, Matsumoto, Matsunami, Nakagawa
- We have decided to start searching genes responsible for 130 human diseases reported by the Intractable Disease Information Center. However, if you have enough time, you can look into all 130 diseases on the data base. Then each member will summarize the results of data base search in the Word file and submit it on our Web site.
7th March
- at laboratory on 3rd floor
- <Participants>
- Yoshimura, Matsumoto, Nakagawa
- ・About incurable diseases
- We will look for the related papers just to make sure everything.
- ・Request of Interview
- The Yomiuri KODOMO news paper company asked us an interview on iGEM. The schedule for the interview is not fixed yet, March 16th would be the cabdidate.
17th March
- at laboratory on 3rd floor
- <Participants>
- Yoshimura, Matsumoto, Matsunami, Nakagawa
- ・About presentations by previous teams
- Today we studied a presentation by 2010 Tokyo－Tech.
22th March
- at laboratory on 3rd floor
- <Participants>
- Yoshimura, Matsunami, Nakagawa
- As is the same as the last meeting, we studied other teams. We discussed on the candidate projects. From now on it will better having knowledge on E. coli and BioBricks.
